3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Melanoma
3
Cholangiocarcinoma
3
Breast Neoplasms
3
Sarcoma
2
Osteosarcoma
2
Liver Neoplasms
2
Kidney Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Unresectable Solid Tumors
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroblastoma
1
Lung Neoplasms
1
Liver Metastasis
1
High-Burden Metastatic Solid Tumors
1
Hepatoblastoma
1
Gastric Cancer Metastatic to Liver
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Desmoid Tumors
1
Colonic Neoplasms
1
Interventions
lenvatinib
3
Gemcitabine
3
tislelizumab
2
pembrolizumab
2
Cisplatin
2
toripalimab
1
titanium silicide
1
theasinensin A
1
surufatinib
1
sitravatinib
1
sintilimab
1
durvalumab
1
S 1 (combination)
1
Nivolumab
1
Folfox protocol
1
Fluorouracil
1
Cryosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Advanced Biliary Tract Cancer
×
Cryosurgery
×
Clear all
NCT05781074
2023-03-24
CASTLE-08
Fudan University
Phase 2
Unknown
25 enrolled